Plants are static creatures. This means that, unlike animals, they cannot simply flee when things get „uncomfortable“. Instead, they have to cope with adverse environmental conditions on the spot. It is therefore particularly important for them to be able to respond very quickly at the genetic level. BionFarming utilises this natural ability to regulate genes and optimises it for the development of new platforms for the production of biologics. 

BionFarming makes it possible to use different plant species according to their specific abilities to produce certain products, thus maximising their natural capabilities. Unlike cell lines, the process does not involve permanent genetic modification, but is limited to a short period until the plant is harvested. These processes are referred to as transient and, in addition to greatly improved flexibility, allow a much faster rate of adaptation, which significantly shortens development times compared to permanently genetically modified animal and human cell lines. These processes are referred to as transient and, in addition to greatly improved flexibility, allow a much faster rate of adaptation, which significantly shortens development times compared to permanently genetically modified animal and human cell lines. 

Glycosylation is a process by which saccharides are attached to proteins. This process is very specific and only certain amino acids are glycosylated. Glycosylation increases the stability of proteins, protects them from proteolytic degradation and determines their activity. Unlike bacterial cell lines, plants are able to express human glycosylation patterns. In addition, we are able to modify plants to produce specific glycosylation patterns that occur in human cells. This makes it possible to produce completely new recombinant proteins, especially those that are difficult to synthesise, which can form the basis of new biopharmaceutical drugs.